ERA (Epigenetic Reprogramming of Aging) technology
GPTKB entity
Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
gptkb:rejuvenation_technology |
| gptkbp:announced |
2020s
|
| gptkbp:application |
regenerative medicine
age-related disease treatment |
| gptkbp:developedBy |
gptkb:Turn_Biotechnologies
|
| gptkbp:mechanismOfAction |
transient mRNA-based reprogramming
|
| gptkbp:purpose |
epigenetic reprogramming
cellular rejuvenation |
| gptkbp:relatedTo |
gptkb:Yamanaka_factors
cellular reprogramming |
| gptkbp:target |
cellular aging
epigenetic marks |
| gptkbp:usedIn |
preclinical studies
|
| gptkbp:bfsParent |
gptkb:Turn_Biotechnologies
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
ERA (Epigenetic Reprogramming of Aging) technology
|